Pain management Flashcards
What is malignant pain?
Tissue damage caused by malignant tumours. tumour in the tissue/organ. can be constant or ‘breakthrough pain’
nociceptive pain: tissue/organ distortion or injury (somatic = bone, muslce) (visceral = gut, bladder)
neuropathic pain: damage to the nerve fibres
define constant pain
constant pain-
tumour causing pressure (distention / stretch)
not affected by position or activity. more likely in confined space (skull, pelvis)
constant and unchanged
what is breakthrough pain
rare flare-up, rapid onset, moderate=severe intensity, short duration,
define neuropathic pain
damage to nerve fibres, peripheral and central nervous system changes
burn, stabbing, hyperaesthesia
unpredictable
less responsive to opioid analgesics
opiate dose equivalent chart
on st Lukes website) (Ratios
codeine is x10 weaker than morphine (60mg codeine= 6mg morphine)
25mcg of fentanyl = 90mg oral morphine
fentanyl is the least constipating (morphine and codeine are very constipating- prescribe laxative and senna)
what is the ratio for breakthrough doses?
a total daily dose of background dose (240)
divide by 6= 40mg
40mg is the breakthrough dose of oramorph
what is the oral oxycodone and oral morphine ratio?
twice as potent as oral morphine
20mg of morphine
/2
10mg oxycodone
what is the oral morphine to subcutaneous diamorphine ratio?
switch from oral to subcut if unable to swallow, nausea and vomiting, dysphagia, last days of care, coma
ratio divide by 3 subcut diamorphine
subcut morphine divide by 2
neuropathic pain tx
corticosteroids
morphine
gabapentin (anticonvulsant)
tapentadol
renal impairment- opiate toxicity
morphine is metabolised to M6G and relies on the kidneys to excrete so if renal impairment, cannot clear their morphine= side effects
drowsy, confused
pinpoint pupils (muscle contraction)
myoclonic jerks
renal impairment- opiate toxicity
morphine is metabolised to M6G and relies on the kidneys to excrete so if renal impairment, cannot clear their morphine= side effects
drowsy, confused
pinpoint pupils (muscle of the iris contraction)
myoclonic jerks
naloxone to reverse opiates
WHO pain ladder
non-opioid +/- adjuvant
opioid for mild-moderate pain + non-opioid + adjuvant
opioid for moderate to severe + nonopioid + adjuvant
MOA opioids
agonist for specific receptor sites at nerve cell synapse
Mu, kappa, delate receptors
weak opioids
oral codeine transdermal buprenorphien (weekly patches) oral tramadol
strong opioids
use is dictated by the therapeutic need, not by prognosis
morphine, diamorphine, alfenanil (injectable), fentanyl, oycodone, tapentadol, methadone